tiprankstipranks
Kraig Biocraft Laboratories Inc (KBLB)
OTHER OTC:KBLB
US Market
KBLB
Kraig Biocraft Laboratories
RESEARCH TOOLSreports

Kraig Biocraft Laboratories (KBLB) Ratios

124 Followers

Kraig Biocraft Laboratories Ratios

KBLB's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, KBLB's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.18 0.18 <0.01 0.29 0.49
Quick Ratio
 0.18 0.18 <0.01 0.29 0.49
Cash Ratio
 0.17 0.17 <0.01 0.29 0.48
Solvency Ratio
 >-0.01 >-0.01 -0.35 -0.34 -0.47
Operating Cash Flow Ratio
 -0.17 -0.17 >-0.01 -0.14 -0.23
Short-Term Operating Cash Flow Coverage
 -34.46 -34.46 -1.14 -0.75 -1.10
Net Current Asset Value
$ -8.70T$ -8.70T$ -8.91M$ -6.37M$ -4.11M
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.07 1.13 0.54 0.39
Debt-to-Equity Ratio
 -21.40K -21.40K -0.21 -0.31 -0.50
Debt-to-Capital Ratio
 1.00 1.00 -0.26 -0.44 -1.01
Long-Term Debt-to-Capital Ratio
 1.00 1.00 0.00 0.00 0.00
Financial Leverage Ratio
 -320.73K -320.73K -0.18 -0.57 -1.30
Debt Service Coverage Ratio
 >-0.01 >-0.01 <0.01 -1.21 -0.90
Interest Coverage Ratio
 -5.91 -5.91 <0.01 -5.40 -3.48
Debt to Market Cap
 1.11K 1.89K 0.02 0.04 0.06
Interest Debt Per Share
 161.55 161.55 -510.03 <0.01 <0.01
Net Debt to EBITDA
 534.78K 534.78K -0.36 0.31 1.00
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
107.38%107.37%110.53%115.87%181.14%
Return on Assets (ROA)
>-0.01%>-0.01%-225.80%-93.73%-84.05%
Return on Equity (ROE)
43.95%45.30%41.71%53.09%109.09%
Return on Capital Employed (ROCE)
<0.01%<0.01%<0.01%46.26%60.58%
Return on Invested Capital (ROIC)
<0.01%<0.01%<0.01%66.06%121.22%
Return on Tangible Assets
>-0.01%>-0.01%-225.80%-93.73%-84.05%
Earnings Yield
-2.44%-4.00%-3.53%-7.58%-12.72%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.05 0.05 0.05 0.05 0.05
Inventory Turnover
 <0.01 <0.01 3.80 4.01 4.27
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 422.44M 422.46M -6.91K -7.07K -6.93K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 422.45M 422.47M 96.05 90.97 85.46
Days of Payables Outstanding
 7.34K 7.34K 7.00K 7.16K 7.02K
Operating Cycle
 422.45M 422.47M 96.05 90.97 85.46
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.69K -1.69K >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 -1.69K -1.69K >-0.01 >-0.01 >-0.01
CapEx Per Share
 5.09 5.09 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 -331.60 -331.60 -433.75 -194.48 -375.86
Capital Expenditure Coverage Ratio
 -331.60 -331.60 -433.75 -194.48 -375.86
Operating Cash Flow Coverage Ratio
 -10.45 -10.45 -1.08 -0.71 -1.06
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-1165394.56%-1980840.25%-1.91%-3.13%-6.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -40.94 -25.00 -28.33 -13.20 -7.86
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 -18.54 -11.32 -11.82 -7.01 -8.58
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 >-0.01 -52.25 -31.97 -15.96
Price-to-Operating Cash Flow Ratio
 >-0.01 >-0.01 -52.37 -32.13 -16.00
Price-to-Earnings Growth (PEG) Ratio
 -14.33 -8.25 -2.05 0.51 0.13
Price-to-Fair Value
 -18.54 -11.32 -11.82 -7.01 -8.58
Enterprise Value Multiple
 534.73K 534.75K -34.24 -15.15 -13.43
Enterprise Value
 -1.62T -1.62T 97.34M 39.19M 28.11M
EV to EBITDA
 534.73K 534.75K -34.24 -15.15 -13.43
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 0.90 0.90 -52.81 -31.33 -14.86
EV to Operating Cash Flow
 0.90 0.90 -52.93 -31.49 -14.90
Tangible Book Value Per Share
 -7.55K -7.55K >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.19 1.19 1.18 1.16 1.81
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.49 0.49 0.54 0.41 0.49
Currency in USD